Results 221 to 230 of about 140,872 (266)

The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromes

Expert Opinion on Biological Therapy, 2008
Mikkael A Sekeres
exaly  

AMG 531 for Chronic ITP

New England Journal of Medicine, 2007
openaire   +2 more sources

MDL 27,531 selectively reverses strychnine‐induced seizures in mice

British Journal of Pharmacology, 1992
John H Kehne, John M Kane, Mark W Dudley
exaly  

[ 11 C]NS9531, [ 11 C]NS9762 and [ 11 C]NS6417, specific SERT tracers: pre-clinical evaluation in pigs and optimization of synthesis conditions using [ 11 C]methyl triflate

Nuclear Medicine and Biology, 2016
Johan Hygum Dam, Dirk Bender, Dan Peters   +2 more
exaly  

The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation

Cancer Discovery, 2018
Rose Mantel, Lisa L Smith, Joseph T Greene   +2 more
exaly  

Engineers (531)

1993
openaire   +1 more source

Abstracts 456 to 531

Pediatric Pulmonology, 2000
openaire   +1 more source

AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP

New England Journal of Medicine, 2006
James B Bussel, David J Kuter, James N George   +2 more
exaly  

Immunomodulation by the new synthetic compound BM 12.531,2-[2-cyanaziridinyl-(1)]-[2-carbamoylaziridinyl-(1)]-propane (azimexone)

Experimental Pathology, 1981
U Bicker, P G Munder
exaly  

531. On Jone

openaire   +1 more source